Citron Research's Andrew Left, who gained notoriety for successful bets against companies such as Valeant Pharmaceuticals, posteda bearish report on cancer testing company Exact Sciences.
The short seller who uncovered Valeant has found his next target in health care
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться